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Adult intensivists have increasing exposure to individuals with congenital diseases surviving into adulthood. Solid knowledge bases
and early recognition of the possible sequelae of congenital disorders are crucial in caring for these patients. We present a
challenging case of shock and relapse of Diamond-Blackfan anemia in a 42-year-old man lost to follow-up for 18 years and
highlighted the importance of healthcare transitions into adulthood and the challenges faced by health care systems to develop
new strategies successfully transitioning complex pediatric patients to adult care.

1. Introduction
Diamond-Blackfan anemia (DBA) is a rare hereditary disorder secondary to a ribosomal protein gene mutation
resulting in erythropoiesis failure, cancer predisposition,
and associated congenital anomalies [1]. The incidence rate
is 7 in 1,000,000 and is inherited mostly in an autosomal
dominant fashion [1]. DBA presents within the ﬁrst year
of life with moderate to severe macrocytic anemia associated with mental retardation, hypertelorism, ﬂat nasal
bridge, high arched or cleft palate, triphalangeal thumb,
and cardiac abnormalities [1–3].
The improvement in treatment modalities and diagnostics has improved the survival of patients with rare congenital
diseases into adulthood by threefold between 2006 and 2016
[4–6]. Increased healthcare complexity highlighted the
importance of transitions of care in decreasing hospital readmissions, system-wide ﬁnancial burdens, and improving
patients’ outcomes [4]. In patients with rare diseases, these

transitions of care are even more important as these patients’
transition into adulthood [7].
Hereby, we report a case of high output cardiac failure
and subsequent shock secondary to a relapse of DBA in a
patient with a history of a repaired Tetralogy of Fallot lost
to follow-up for 18 years highlighting the importance of close
follow-up and transitions between pediatric and adult
providers.

2. Case Presentation
A 42-year-old Caucasian male presented with worsening
fatigue and dyspnea for 2 weeks. His medical history
included a diagnosis of childhood Diamond-Blackfan anemia
(DBA), for which he received corticosteroids until the age of
24 when he was lost to follow-up, and a Tetralogy of Fallot
(TOF) with pulmonary atresia repaired at the age of 3 years
with a right ventricle-pulmonary artery conduit. He denied
any bleeding, and a complete review of systems was
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Figure 1: Initial electrocardiogram (EKG) demonstrating right bundle branch block, right axis deviation, and sinus tachycardia.

otherwise negative. His vital signs demonstrated a blood
pressure of 138/90 mmHg, tachypnea (respiratory rate: 30
breaths/minute), tachycardia (pulse rate: 110 beats/minute),
and a temperature of 36.4°C, and he was saturating 88% on
a nonrebreather mask. He appeared in visible respiratory distress and pale and had evidence of a Klippel-Feil deformity, a
triphalangeal thumb, and a harsh diastolic murmur over the
left sternal border.
His labs demonstrated profound anemia with an hemoglobin of 2.5 g/dl, an elevated white blood cell count of 26.4
cells/mm3, and a normal platelet count. His serum creatinine
was 1.02 mg/dl, and his serum lactic acid was 6.3 mmol/L.
Liver chemistries demonstrated elevated aspartate aminotransferase of 1072 U/L, alanine aminotransferase of
1568 U/L, and total bilirubin of 3.2 mg/dl. His international
normalized ratio (INR) was 3.2, and his activated partial
thromboplastin time (aPTT) was 49.5 seconds. A brain natriuretic peptide (BNP) was elevated at 2942 pg/ml. A thyroid
stimulating hormone (TSH) level was normal. A chest Xray (CXR) demonstrated cardiomegaly and pulmonary
edema. An electrocardiogram (EKG) demonstrated a right
bundle branch block (RBBB), a posterior left fascicular block,
and sinus tachycardia (Figure 1).
Progressive worsening of clinical status with bilevel positive airway pressure (BiPAP) prompted intubation and
mechanical ventilation. He was transfused 6 units of packed
red blood cells (PRBC) with improvement of his hemoglobin
to 8.8 g/dl. He received concomitant doses of furosemide to
avoid further volume overload. He required norepinephrine
for hemodynamic instability for 48 hours. A repeat echocardiogram demonstrated severe right ventricular enlargement

Figure 2: Transthoracic echocardiogram (TTE) demonstrating
right sided ventricular hypertrophy.

(Figure 2). He was extubated after three days of optimizing
his volume and respiratory status, and his liver chemistries,
INR, and serum lactate normalized. Figure 3 compares an
initial CXR and one performed at day 4. He was diuresed
gently and discharged after 7 days of admission. A cardiac
magnetic resonance image (MRI) showed a normal left ventricular ejection fraction (EF) of 55%, a severely enlarged
right atrium and right ventricle (RV) with marked depression
in right ventricular function (RV EF: 18%) (Figure 4), and
severe bioprosthetic pulmonary regurgitation. His anemia
was attributed to a relapse of his DBA, and he was restarted
on prednisone. On 2 years of follow-up, he continues to
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Figure 3: Initial plain chest ﬁlm demonstrating acute pulmonary edema and repeat study at four days of hospitalization with improvement in
volume overload. Congenital rib deformity and pulmonic valve ring are visible in both images.

Figure 4: Cardiac magnetic resonance imaging demonstrating marked right ventricular enlargement.

refuse a bone marrow transplant, is transfusion-dependent,
and is planned for a percutaneous pulmonary valve replacement. On evaluation of reasons for loss to follow-up, the
patient reported a traumatic experience receiving a bone
marrow aspiration in his adolescence.

3. Discussion
DBA diagnosis requires a correlation between examination
ﬁndings and laboratory abnormalities demonstrating macrocytic anemia, elevated hemoglobin F levels, high erythrocyte deaminase activity, and conﬁrmation with bone
marrow biopsy and gene karyotyping. DBA is associated
with congenital heart disease (CHD) in 30% of patients with
atrial and ventricular septal defects constituting the majority of associated anomalies [1–3]. Associated Tetralogy of
Fallot (TOF) accounts for only 3.5% of associated anomalies, and pulmonary hypertension following TOF repair
occurs in around 1% of patients and often seen in patients

with major aortopulmonary collateral arteries [1–3]. DBA
management requires cooperation and coordination
between multiple specialties given the complexity of the disorder and its eﬀect on diﬀerent organs. High dose followed
by maintenance steroids and supportive transfusions represent initial lines of therapy with bone marrow transplantation utilized as deﬁnitive therapy in patients failing to
achieve or maintain remission [8, 9]. Pregnancy and viral
infections can cause relapse of the anemia with the latter
being a possible trigger in the reported patient [8, 9].
Our patient presented with severe anemia resulting in
high-output cardiac failure precipitating shock in the setting
of severe pulmonary hypertension following a repaired TOF.
This case represents several missed opportunities for earlier
intervention that could have prevented the signiﬁcant morbidity that our patient endured because of loss to follow-up.
Firstly, early recognition of DBA relapse and reintroduction
of steroids could have treated his anemia. Additionally, serial
monitoring for development of pulmonary regurgitation,
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pulmonary hypertension, and subsequent right ventricular
failure prompting early consideration for pulmonic valve
replacement.
Multiple factors contribute to fractured transitions of
care into adulthood including improper planning and coordination and low adult provider comfort levels and familiarity with chronic and complex pediatric diseases [10]. Patient
factors include psychological eﬀects of chronic disease on
children and adolescents and lack of access to advanced
healthcare and resources in rural populations [7, 11]. Eﬀorts
to create safer transitions of care for pediatric patients transitioning into adulthood are needed to prevent additional morbidity and mortality.
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